We have a proud tradition in developing novel treatments for stroke. 91ΒιΆΉ has a long tradition of investigator-initiated stroke clinical stroke trials, translational stroke research, and both leading and participating in NIH-sponsored cooperative trials. Our activities have spanned the phases of clinical trial activities from a strong pre-clinical βtranslationalβ program that has developed the scientific rationale and premise for clinical trials, to phase I and II trials that have established dosing, safety and pharmacokinetics, and finally to phase III trials designed and initiated to establish efficacy.
Click here for info on CURRENT RESEARCH STUDIES Click here for info on COMPLETED RESEARCH STUDIES
PISCES III : A CLINICAL RESEARCH STUDY OF STEM CELLS FOR PATIENTS WITH ONGOING DISABILITY AFTER STROKE
**Right now this phase of the trial only accepts patients that have had a stroke in the last 6-12 months.
